Impact of rolapitant on quality of life (QoL) in patients (pts) receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC). Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chasen, Martin
  • Urban, Laszlo
  • Schnadig, Ian
  • Rapoport, Bernardo Leon
  • Poma, Allen
  • Arora, Sujata
  • Navari, Rudolph M
  • Schwartzberg, Lee Steven
  • Gridelli, Cesare

publication date

  • May 20, 2015